Stock Track | Vigonvita Life Sciences Soars 5.29% Intraday on Proposed Capital Increase After H-Share Listing

Stock Track

04/01

Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) saw its stock price soar 5.29% during intraday trading on Wednesday, reflecting significant investor interest.

The surge follows the company's announcement proposing amendments to its Articles of Association to increase its registered capital from RMB150 million to approximately RMB168 million. This update formalizes changes following the company's H-share listing in November 2025 and is scheduled to be voted on at an extraordinary general meeting set for late April.

Investors appear to be responding positively to these corporate governance steps, which solidify the capital structure after the H-share IPO and may signal continued growth initiatives. The company's focus remains on pharmaceutical manufacturing, contract drug production, and biomedical R&D.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1119592422"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1119592422\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1119592422?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-01 09:59","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1119592422","market":"hk","top_or_hot":-1,"title":"Stock Track | Vigonvita Life Sciences Soars 5.29% Intraday on Proposed Capital Increase After H-Share Listing","media":"Stock Track","content":"<p>Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) saw its stock price soar 5.29% during intraday trading on Wednesday, reflecting significant investor interest.</p><p>The surge follows the company's announcement proposing amendments to its Articles of Association to increase its registered capital from RMB150 million to approximately RMB168 million. This update formalizes changes following the company's H-share listing in November 2025 and is scheduled to be voted on at an extraordinary general meeting set for late April.</p><p>Investors appear to be responding positively to these corporate governance steps, which solidify the capital structure after the H-share IPO and may signal continued growth initiatives. The company's focus remains on pharmaceutical manufacturing, contract drug production, and biomedical R&D.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Vigonvita Life Sciences Soars 5.29% Intraday on Proposed Capital Increase After H-Share Listing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Vigonvita Life Sciences Soars 5.29% Intraday on Proposed Capital Increase After H-Share Listing\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-04-01 09:59</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) saw its stock price soar 5.29% during intraday trading on Wednesday, reflecting significant investor interest.</p><p>The surge follows the company's announcement proposing amendments to its Articles of Association to increase its registered capital from RMB150 million to approximately RMB168 million. This update formalizes changes following the company's H-share listing in November 2025 and is scheduled to be voted on at an extraordinary general meeting set for late April.</p><p>Investors appear to be responding positively to these corporate governance steps, which solidify the capital structure after the H-share IPO and may signal continued growth initiatives. The company's focus remains on pharmaceutical manufacturing, contract drug production, and biomedical R&D.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02630","symbol_name":"旺山旺水-B","start_time":0,"source_url":"","article_id":"1119592422","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1119592422","pubTimestamp":1775008770,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) saw its stock price soar 5.29% during intraday trading on Wednesday, reflecting significant investor interest.The surge follows the company's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02630":"旺山旺水-B"},"translate_title":"股票赛道|H股上市后拟增资Vigonvita生命科学盘中大涨5.29%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02630":1},"content_text":"Vigonvita Life Sciences Co., Ltd. (VIGONVITA-B) saw its stock price soar 5.29% during intraday trading on Wednesday, reflecting significant investor interest.The surge follows the company's announcement proposing amendments to its Articles of Association to increase its registered capital from RMB150 million to approximately RMB168 million. This update formalizes changes following the company's H-share listing in November 2025 and is scheduled to be voted on at an extraordinary general meeting set for late April.Investors appear to be responding positively to these corporate governance steps, which solidify the capital structure after the H-share IPO and may signal continued growth initiatives. The company's focus remains on pharmaceutical manufacturing, contract drug production, and biomedical R&D.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}